"This finding suggests that it may be beneficial to reassess the preoperative withholding guidelines for GLP-1 RAs." HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

Poor nutritional status and increased severity of pneumonia were associated with higher mortality rates among patients with aspiration pneumonia, according to a recent study. “Aspiration pneumonia is ...

European medical officials advised patients taking GLP-1 weight loss and diabetes drugs who will be sedated for an upcoming surgery to warn their doctors about their medication use to avoid the risk ...

On a follow-up visit to the pulmonologist, she is told that she had a severe case of community-acquired pneumonia (CAP), likely caused by her close work with children. However, the lack of positive ...

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may lead to an increased risk for aspiration pneumonia after endoscopic procedures, according to a new large population-based study. In ...

The study was prompted by an increase in colonoscopies performed with propofol, a common ambulatory anesthesia drug. Researchers from Case Western Reserve University in Cleveland reviewed 5 percent of ...

Compared with 0.63% of non-users, 0.83% patients on a GLP-1 receptor agonist experienced aspiration pneumonia within a month of the procedure, Kevin Sheng-Kai Ma, DDS, of Brigham and Women's Hospital ...

New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.

Please provide your email address to receive an email when new articles are posted on . Glucagon-like peptide-1 receptor agonists were associated with a higher risk for aspiration pneumonia after ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. There was also no significant difference in the odds of acute respiratory failure.